Suchergebnisse - "Ueno, Takayuki"

PubPharm (12)

1

Pertuzumab retreatment for HER2-positive advanced breast cancer : A randomized, open-label phase III study (PRECIOUS)

enthalten in: Cancer science | 2022

von Yamamoto, Y. | Iwata, H. | Taira, N. | +19

2

Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer : Japan Breast Cancer Research Group (JBCRG)22 TR

enthalten in: BMC medicine | 2022

von Ueno, T. | Kitano, S. | Masuda, N. | +18

3

HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer : an international multicentre cohort study and TCGA-METABRIC analysis

enthalten in: BMC medicine | 2022

von Tan, R. | Ong, W. | Lee, K. | +20

4

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer : a multicentre, open-label, randomised, controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Toi, M. | Imoto, S. | Ishida, T. | +22

ErratumIn: Lancet Oncol. 2022 Oct;23(10):e446. - PMID 36174627

5

Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer : the JBCRG-10 study

enthalten in: Japanese journal of clinical oncology | 2020

von Ueno, T. | Masuda, N. | Sato, N. | +10

6

Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer : A multicenter, open-label, phase II study

enthalten in: Cancer medicine | 2019

von Sato, N. | Masuda, N. | Morimoto, T. | +9

7

Circulating Tumor DNA in HER2-Amplified Breast Cancer : A Translational Research Substudy of the NeoALTTO Phase III Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Rothé, F. | Silva, M. | Venet, D. | +20

8

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer : JBCRG-07TR

enthalten in: International journal of molecular sciences | 2019

von Ueno, T. | Masuda, N. | Kamigaki, S. | +5

9

A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07) : therapeutic efficacy and clinical implications of circulating endothelial cells

enthalten in: Cancer medicine | 2018

von Ueno, T. | Masuda, N. | Kamigaki, S. | +8

10

A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study)

enthalten in: Cancer medicine | 2017

von Ishiguro, H. | Saji, S. | Nomura, S. | +7